The ergogenic effects of caffeine in human exercise have been shown to improve endurance and 30 anaerobic exercise performance. Previous work has demonstrated that 70μM caffeine (physiological 31 maximum) can directly increase mouse extensor digitorum longus (EDL) muscle power output (PO) 32 in sprint like activity by 3%. Our study used the work loop technique on isolated mouse muscles to 33 investigate whether the direct effect of 70μM caffeine on PO differed between: 1) maximally and 34 sub maximally activated muscle; 2) relatively fast (EDL) and relatively slow (soleus) muscles; 3) 35 caffeine concentrations. 70μM caffeine treatment resulted in significant improvements in PO in 36 maximally and sub maximally activated EDL and Soleus (P <0.03 in all cases). For EDL the effects of 37 caffeine were greatest when the lowest, submaximal, stimulation frequency was used (p<0.001). 38 140, 70 and 50μM caffeine treatments resulted in significant improvements in acute PO for both 39 maximally activated EDL (3%) and soleus (6%) (P <0.023 in all cases), however there was no 40 significant difference in effect between these concentrations (p>0.420 in all cases). Therefore, the 41 ergogenic effects of caffeine on power output was higher in muscles with a slower fibre type (P 42 <0.001). Treatment with 35μM caffeine failed to elicit any improvement in PO in either muscle (P 43 >0.72 in both cases). Caffeine concentrations below the physiological maximum can directly 44 potentiate skeletal muscle power output. This caffeine induced increase in force could provide 45 similar benefit across a range of exercise intensities with greater gains likely in activities powered by 46 slower muscle fibre type. 47
Introduction
mechanism by which caffeine can promote enhanced force output in skeletal muscle is believed to 80 be via interference of excitation contraction coupling (8). It has been established that the specific 81 mechanism of action is alteration of intramuscular ion handling, primarily via an increased 82 concentration of Ca 2+ within the intracellular space (23). However, little is known about whether 83 variation in physiological conditions, such as intensity of exercise and caffeine dosage, will alter the 84 direct response of muscle to caffeine during human physical activities. Tarnopolsky & Cupido (29) 85 reported that 6 mg.kg -1 body mass (approximately 60μM in blood plasma) of caffeine enhanced 86 involuntary evoked skeletal muscle force in human subjects at low, but not high stimulation 87
frequencies. This was attributed to a potentiation of calcium release at lower stimulation 88 frequencies promoting a greater influx of Ca 2+ in the presence of caffeine. However, no previous in 89 vitro study has directly tested isolated muscle to determine whether the enhancement of force and 90 power production in skeletal muscle, due to caffeine treatment, is greater at lower stimulation 91 frequencies. Such findings would be of practical benefit to athletes as they would indicate the types 92 of physical activities in which the ergogenic effects of caffeine were greatest. 93 James et al (16, 17) were the first to test the effect of physiologically relevant concentrations of 94 caffeine (70μM human in vivo maximum, 13) using the work loop technique. They found a small but 95 significant, 2-3%, increase in mean net power output in maximally activated isolated mouse EDL (fast 96 muscle), attributed to increased force production during shortening. 70μM caffeine treatments had 97 no significant effect on delaying the onset of fatigue or enhancing fatigue recovery. Evidence from 98 over physiologically relevant caffeine concentrations, therefore, there are currently no studies to 106 indicate the dosage of caffeine required for humans to maximise power output in muscle during 107 physical activity. 108
The present study aims to investigate whether maximal physiological concentrations (70μM) of 109 caffeine directly affect the power output of isolated skeletal muscle during brief bouts of cyclical 110 activity, being the first such study to compare between: 1) maximally and sub maximally activated 111 muscle; 2) relatively fast extensor digitorum longus (EDL) and relatively slow soleus muscles; 3) 112 micromolar concentrations (35-140μM) of caffeine. 113
Materials and Methods 114
Dissection 115
The use of animals in this study was approved by the ethics committee of Coventry University. 116
Female white mice (strain CD1 mice, Charles River, UK) were bred and kept at Coventry University. 8 117 -10 week old mice (body mass = 30.2 ± 0.81g, mean ± SE, n = 108) were weighed and then killed by 118 2.54; pH 7.55 at room temperature prior to oxygenation. For each preparation the tendon and a 125 small piece of bone was left attached at the proximal and distal ends. Aluminium foil T-clips were 126 wrapped around each tendon leaving the bone at the back of the clip to help minimise tendon 127 slippage when the muscle was producing force (16). 128
Isometric Studies 129
Foil clips were used to attach the muscle preparation via crocodile clips, at one end to a force 130 transducer (UF1, Pioden Controls Ltd, UK) and at the opposing end to a motor (V201, Ling Dynamic 131
Muscle length and stimulus amplitude (12-16V for soleus; 14-18V for EDL) were optimised in order 139 to achieve maximal isometric twitch force. The muscle length that corresponded to maximal 140 isometric twitch force was measured using an eyepiece graticule fitted to a microscope and was 141 defined as L 0 . Mean muscle fibre length was calculated as 85% of L 0 (15). Maximal isometric tetanic 142 force was measured by subjecting the preparation to a burst of electrical stimuli (320 ms for soleus; 143 200 ms for EDL). Stimulation frequency was optimised to yield maximal tetanic force (normally 144 140Hz for soleus; 200Hz for EDL), following this further tetanic responses were measured at 2 sub 145 maximal stimulation frequencies (70 & 40Hz for soleus; 150 & 100Hz for EDL). A 5 minute rest period 146 was imposed between each tetanus in order to ensure the muscle had sufficient recovery time. 147
The same isometric protocol was used for all EDL and soleus preparations before beginning the work 148 loop experiments to determine the acute effects of caffeine. 149
Work Loop Studies 150
The work loop technique assesses the ability of the muscle to produce power whilst undergoing 151 cyclical length changes (16, 18, 19) . Here the muscle was held at L 0 and the stimulation amplitude 152 and frequency parameters that yielded maximal tetanic force were employed. Each muscle was 153 subjected to four sinusoidal length change cycles per set at a total symmetrical strain of 0.10, thus 154 the muscle lengthened by 5% from L 0 followed by a shortening to 5% shorter than L 0 before 155 returning back to L 0 at a cycle frequency of 5Hz. 5Hz cycle frequency was used for soleus 156 preparations as it represents the cycle frequency that has previously been shown to elicit maximal 157 power output in mouse soleus muscle and is attainable in running mice (3, 15). 5Hz was also used for 158 EDL preparations in order to enable a direct comparison with soleus muscles, however maximal 159 power output for EDL is achieved at 10Hz cycle frequency (15). The strain used comes from previous 160 estimation of strains that produce maximal power output at 5Hz in soleus and EDL and that are 161 attainable during in vivo locomotion (15, 30) . Muscle stimulation and length changes were8 (KPCI3108, Keithley Instruments, Ohio, USA). Data were sampled at a rate of 10 kHz and then a work 164 loop was formed, by plotting force against length, the area of which represents the net work done 165 by the muscle during a single length change cycle (19). The preparations were electrically stimulated 166 by altering burst duration until maximal net power output was achieved. 167
A burst duration of 100 ms was found to elicit maximal power output in EDL, consistent with the 168 findings of James et al (16, 17) . The burst duration dictates the number of stimuli that the muscle 169 receives during the work loop; optimising this duration maximises power output. Usually a burst 170 duration of 65 ms was found to elicit maximal power output in soleus, consistent with the findings of 171 James et al (16, 17) and Vassilakos et al (30) . However, on occasions when subjecting soleus to a 172 40Hz stimulation frequency the burst duration was lengthened to 76 ms adding a further stimulus 173 during the shortening phase of the work loop. This adjustment was determined by examining power 174 output values. If the muscle is was too active during lengthening there is greater resistance to 175 elongate the muscle back to resting length and therefore a decreased net power output. A 176 stimulation phase shift of -10 ms was fixed for all preparations in the present study (30). The 177 stimulation phase shift dictates that stimulation of the muscle starts 10 ms prior to the muscle 178 reaching maximal length, therefore with a stimulus duration of 65ms in soleus, stimulation continues 179 until 45 ms prior to the muscle reaching its shortest length. 180
Prior to commencement of testing, muscle power output was measured at maximal and sub 181 maximal stimulation frequencies in all the preparations used (140, 70 & 40Hz for soleus; 200, 150 & 182 100Hz for EDL). The second loop of each set of four work loops was used as an indicative measure 183 for each trial as it didn't prove to be different from loop 3. Following this all the length and 184 stimulation parameters were kept constant and a 10 minute rest between each trial was enforced in 185 order to allow maximal recovery time (17). Prior to commencement of testing, muscle stress and power output at 140Hz, 70Hz and 40Hz for 210 soleus and 200Hz, 150Hz and 100Hz for EDL were measured in all the preparations used. Two factorwere subsequently placed. Therefore, stimulation frequency and caffeine treatment category were 214 used as the fixed factors and power output as the dependant variable. Tukey post hoc tests were 215 performed for stimulation frequency where any significant differences were found. 216
Prior to testing the effect of 70μM caffeine over different stimulation frequencies, there was no 217 significant difference in stress and power output between caffeine treatment categories in soleus 218
and EDL (ANOVA p <0.65 in all cases) prior to caffeine treatment. Prior to testing the effects of 219 different caffeine concentrations there was no significant difference in stress and power output 220 between treatment categories in EDL (ANOVA p = 0.723). In soleus the 50μM treatment group 221 produced significantly more stress than 35μM group (ANOVA Tukey p<0.001), however there was no 222 significant difference between any of the other treatment groups (Tukey p>0.505 in all cases). For 223 soleus and EDL there was no significant difference in power output between the treatment 224 categories (p=0.695 in both cases). A reduction in stimulation frequency resulted in a reduction in 225 stress and power in all treatment groups for both EDL and soleus (ANOVA p<0.001 in all cases). 226
Therefore it is fair to conclude the preparations were of similar quality prior to treatment. 227
Muscle power output will decrease over time due to the gradual development of an anoxic core. In 228 order to avoid deterioration in muscle performance masking the effects of caffeine, a 1 st order 229 regression equation was calculated using the control data and washout data in order to identify the 230 linear relationship between muscle power output and time. This regression equation was then used 231 to determine theoretical control muscle power output for each time point during caffeine 232 treatment. The range of regression coefficients were R 2 = 0.002-0.9972, the level of significance 233 between these regressions varied between p < 0.001 -0.883. Typically muscle preparations that 234 demonstrated a degree of deterioration over time showed significant regression coefficients 235 normally exceeding 0.8 (p<0.05 in each case). Preparations that were stable over time had low 236 regression coefficients and the effect of the correction was minimal. 237 A single factor ANOVA was conducted on each treatment group in order to determine any difference 238 between prior treatment control and post treatment washout. For soleus and EDL muscles there was 239 no significant difference between the prior and post treatment controls. Therefore, it is assumed 240 that after the caffeine treatment the muscles returned to their previous state and any changes in 241 performance during treatment were solely the effects of caffeine. These control data were pooled 242 and subsequent analysis was conducted comparing caffeine treatment directly against controls. 243
The effects of stimulation frequency (100Hz, 150Hz, 200 Hz) and caffeine treatment (70uM, control) 244
on soleus power output were tested in 2-factor (3x2) ANOVA. The same statistical test was 245 conducted in a separate 2-factor (3x2) ANOVA for the EDL muscle. In order to test for a significant 246 effect of caffeine concentration a further 2 factor (2x3) ANOVA was conducted separately for soleus 247 and EDL. Again power output was the dependant variable with caffeine treatment (70μM caffeine or 248 control) and caffeine concentration as the fixed factors. A significant interaction between 249 concentration and treatment was identified in EDL treated with 70μM caffeine at different 250 stimulation frequencies and both soleus and EDL treated with altered caffeine concentrations (two 251 factor (2x3) ANOVA p <0.015 in all cases), therefore we conducted a single factor ANOVA on each 252 treatment group to determine the effect of caffeine compared to control. 253
Results were interpreted as significant when p < 0.05. Values are displayed as mean ± standard 254 error. 255
Results

256
EDL produced significantly greater stress and greater PO than soleus (Table 1; single factor ANOVA  257 main effect p<0.001 in both cases). Reducing stimulation frequency resulted in a significant 258 reduction in stress (to 87.8% and 66.4% of maximal for soleus when stimulated at 70 and 40Hz and 259 to 91.1% and 69.6% of maximum for EDL when stimulated at 150Hz and 100Hz) for both soleus and 260 EDL (Table 1 ; two factor (2x3) ANOVA main effect p<0.001 in both cases). A reduction in stimulation 261 frequency also resulted in a significant decrease in maximum work loop stress (to 64.3% and 42.9% 262 of maximum for soleus when stimulated at 70 and 40Hz and to 87.1% and 59.5% of maximum for 263 EDL when stimulated at 150Hz and 100Hz) in soleus and EDL (Table 1; Treatment of soleus muscle with 140μM, 70μM and 50μM caffeine resulted in a significant increase 284 in maximal power of up to 6% (Fig 5 single factor ANOVA main effect p<0.015 in all cases) . 285
Treatment using 35μM caffeine failed to significantly increase soleus muscle's maximal PO (Fig 5  286 single factor ANOVA main effect p= 0.072). There was no significant difference in the increase in PO 287 between 140μM, 70μM and 50μM caffeine treatments (Fig 5; two factor (2x3) ANOVA Tukey p< 288 0.473 in all cases). 289
Treatment of EDL muscle with 140μM, 70μM and 50μM caffeine resulted in a significant increase in 290 mean maximal power of up to 3.3% (Figure 6 ; single factor ANOVA main effect p<0.022 in all cases). 291
Treatment using 35μM caffeine failed to significantly increase EDL muscles maximal PO (Figure 6 ; 292 single factor ANOVA main effect p= 0.341). There was no significant difference in the increase in PO 293 between 140μM, 70μM and 50μM caffeine treatments ( Figure 6 ; two factor (2x3) ANOVA Tukey p > 294 0.421 in all cases). 295
As there was no significant difference in response between 140μM, 70μM and 50μM caffeine 296 treatments these results were pooled and soleus was compared against EDL. Treatment of soleus 297 muscles with 50μM -140μM caffeine resulted in a significantly greater increase in power output 298 (4.7%) compared to EDL (2.5%) muscle (Figure 7 ; ANOVA two factor (2x3) main effect p <0.001) 299
Discussion 300
The mean maximal isometric tetanic stress was 189 ± 12 kN m -2 and 300 ± 23 kN m -2 for soleus and 301 extensor digitorum longus (EDL) respectively (Table 1) . This is similar to soleus but notably higher for 302 EDL stresses previously reported by James et al (15, 17) Vassilakos et al (30). Any differences in stress and power output between studies could be attributed 306 to muscle fibre type differences due to variation in strain and age of the mice and the environmental 307 conditions at which they were kept. Variation in muscle mass and length will also affect the maximal 308 stress and power that the muscle can achieve. 309
The effects of 70μM caffeine on muscle power output at maximal and sub maximal stimulation 310 frequencies. 311
Treatment of mouse EDL and soleus muscle with 70μM caffeine elicited significantly greater power 312 output. A mean increase in soleus power output of approximately 6% occurred at each stimulation 313 frequency (Fig 1) . In EDL the caffeine induced enhancement of power output decreased with 314 increased stimulation frequency from 6.7% at 100Hz to 3.3% at 200Hz (Fig 2) . The ergogenic benefit 315 was not significantly different between stimulation frequencies in soleus, however a lower 316 stimulation frequency (100Hz) produced significantly greater force in EDL compared to higher 317 stimulation frequencies. Therefore, in EDL the effects of caffeine on power output were greater 318 when the lowest, submaximal, stimulation frequency was used. 319
A caffeine treatment induced elevation in muscle power output supports the finding of James et al 320 (16) who also used a physiologically relevant 70 μM caffeine concentration to treat maximally 321 stimulated EDL. The 3.3% increase obtained in EDL in the present study using the same parameters is 322 similar to the 2-3% increase reported by James et al (16) , but markedly lower than the 6.4% power 323 improvement seen in soleus in the present study. These results from the present study suggest that 324 in mammals physiological levels of caffeine treatment will directly induce small increases in power 325 output in short term high intensity activity (e.g.100m sprint in athletics) however, it seems likely that 326 caffeine will have greater ergogenic benefit during lower intensity sporting activities that are 327 primarily powered by slow muscle fibre types. 328
It has long been established that caffeine can alter excitation-contraction coupling (23). The 329 mechanism by which this increase in power output has occurred in the present study can be 330 attributed to the ability of caffeine to alter intramuscular ion handling. The mechanism for this 331 action of caffeine is still unclear, however, it is believed that caffeine operates directly as an 332 adenosine receptor antagonist on A1 receptors on the skeletal muscle membrane and/or binds to 333 RYR receptors of the SR as shown in vitro with 10mM caffeine treatment and in RYR -/-mice (4, 7, 334 10, 27). These processes probably result in a combination of improved opening of the RyR2 channels 335 of the SR stimulating a greater release of Ca 2+ into the intracellular space, an increase in myofibrillar 336 Ca 2+ sensitivity, a decrease in the sensitivity of the SR Ca 2+ pump, and an increased SR Ca 2+ 337 permeability. Consequently the rate of Ca 2+ efflux from the intracellular space back to the SR may be 338 significantly slower resulting in a greater basal and activated intracellular Ca 2+ concentration, hence 339 increased relaxation time (1, 2). The work loop shapes for both EDL and soleus (Fig 8) show that 340 caffeine treatment caused a direct increase in muscle force during shortening, however, no 341 appreciable change in relaxation time can be seen. As the muscle was only subjected to 4 work loop 342 cycles it is unlikely that the proposed increase in basal Ca 2+ between stimulations will occur over this 343 short time period. Fryer and Neering (11) Generally in vivo and in vitro studies report the benefit of caffeine as a group mean (2, 5, 17, 26) , 358 however a degree of inter-individual variability in response is common and studies have shown that 359 not all individuals show a performance improvement (5, 8, 16) . In the present study there were also 360 individual muscles that showed no appreciable change in power output in response to caffeine (Fig 3  361 & 4). To the authors knowledge caffeine has not been demonstrated to cause a reduction in acute 362 muscle force, therefore from a human perspective, micromolar concentrations of caffeine in human 363 blood plasma can most likely have direct beneficial or negligible effects on skeletal muscle 364 performance. 365
Tarnpolsky & Cupido (29) suggested that at a sub maximal stimulation frequencies caffeine would 366 promote greater release of Ca 2+ . The present study doesn't fully support this finding as there were 367 no significant increases in soleus muscle power output with decreased stimulation frequency. EDL 368 showed a similar response when 200Hz (maximal) was compared against 150Hz, however, a 369 significant enhancement in muscle power did occur at 100Hz. For this treatment group there 370 appeared to be no 'non responders' to the caffeine treatment (Fig 4; C) hence the mean increase in 371 power output was significantly higher than at 200Hz and 150Hz. As the precise mechanism of the 372 action of caffeine is still unknown we are unable to suggest that a greater number of responders 373 occur at lower stimulation frequencies. Overall our findings suggest that there is a limit to the level 374 of calcium influx that caffeine promotes and further highlights the need for greater investigation into 375 the mechanisms of the response. 376
The effects of 35, 50, 70 and 140μM concentrations of caffeine on maximal force production 377 140μM, 70μM and 50μM caffeine treatment resulted in significant improvements in mean power 378 output of mouse soleus (up to 6%; Fig 5) and EDL muscle (up to 3.3%; Fig 6) . There were no 379 significant differences in the level of ergogenic benefit between each concentration. Treatment of 380 soleus and EDL with 35μM caffeine failed to potentiate force. 381
Human physiological concentrations of caffeine are very rarely above 70μM with common plasma 382 levels being between 20-50μM (10, 13). The present study indicates that there appears to be a 383 threshold level of caffeine concentration, below which there is no response and above which there is 384 no further effect of increasing concentration within the physiological range. The effect of 6 or 9 385 mg.kg The effects of caffeine on different muscle fibre types 395
The ergogenic benefit was significantly greater in mouse soleus (4.7%) compared to EDL (2.5%; Fig  396   7 ). This is comparable to previous evidence, using non-physiological concentrations of caffeine, 397 where fast twitch fibres yielded a greater response to caffeine treatment than slow twitch fibres. 398
Rossi et al (27) reported a greater response to 2-30mM caffeine concentrations in mouse soleus 399 compared to EDL. Fryer and Neering (11) further demonstrated that soleus was more sensitive to a 400 lower dose (200μM) of caffeine compared to EDL. This can be attributed to muscle specificdifferences in Ca 2+ kinetic properties and muscle specific expression of RYR isoforms between type I 402 and II fibre types (23). Rossi et al (27) reported that mouse skeletal muscle RYR3 receptors have a 403 greater sensitivity to caffeine than RYR1. It has been established that muscles with the greatest 404 response have a greater quantity of RyR3. A higher quantity of RyR3 is evident in soleus muscle 405 explaining the elevated response of soleus in the present study (27) . 406
When relating these results in a broader context to human performance it should be considered that 407 caffeine has a shorter half life in rodents and differences in metabolism also occur between rodents 408 and primates (10). Fibres treated with caffeine may in vivo be modulated to produce the same 409 power as controls with the activation of fewer muscle fibres. In vivo the pattern of fibre stimulation 410 along with length change waveforms are likely to be manipulated throughout movement in order to 411 maximise muscle economy and prevent the onset of fatigue (31). However, these differences are 412 unlikely to affect the overall findings of the study. 413
In conclusion physiological levels of caffeine (50 & 70μM) can directly enhance mouse soleus and 414 EDL muscle power output during short term cyclical activity. Further to this caffeine appears to have 415 no dose dependant effect on skeletal muscle when used over a relatively small concentration range 416 (50-140μM). The current study shows that caffeine doses lower than the physiological maximum can 417 produce significant improvements in muscle force. Treatment with 35μM caffeine showed no 418 appreciable change in the power output of either soleus or EDL, therefore it is assumed that a 419 relatively high concentration of caffeine is needed to evoke physiological benefit directly at the 420 skeletal muscle. From the results of the current study it appears that the extent of caffeine induced 421 potentiation of power output is unlikely to differ between muscle stimulated sub maximally 422 compared to maximally. 
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